UBS analyst Dennis Geiger maintains Wingstop (NASDAQ:WING) with a Neutral and raises the price target from $145 to $190.
Tiziana Life Sciences Ltd. Receives Nasdaq Deficiency Notice
Tiziana Life Sciences (Nasdaq: TLSA) ("Tiziana" or the "Company"), a biotechnology company developing breakthrough immunomodulation therapies via novel routes of drug delivery, today disclosed